Navigation Links
Galmed Pharmaceuticals Reports First Half 2014 Financial Results
Date:7/25/2014

span>

$
Liabilities and Stockholders' DeficiencyCurrent liabilitiesTrade payables$
301

$
,355
Other accounts payable393

334Total current liabilities694

1,689Long-term liabilities Related parties442

428Total long-term liabilities442

428Stockholders' equity (deficiency):Ordinary shares par value NIS 0.01 per share; 
Authorized 50,000,000; Issued and outstanding:
11,100,453 shares as of June 30, 201432

-Ordinary shares par value $1 per share; Authorized 50,000
shares; Issued and outstanding: 9,739 shares as of
December 31, 2013-

10Additional paid-in capital67,876

25,681Accumulated deficit (31,560)

(27,642)Total stockholders' equity (deficiency)36,348

(1,951)Total liabilities and stockholders' equity$
37,484

$
The noted included in the 6-K are an integral part of the condensed interim consolidated financial statements. GALMED PHARMACEUTICALS LTD.Condensed Consolidated Statements of OperationsU.S. Dollars in thousands, except share data and per share dataSuccessorPredecessor 

Period from February 3 to June 30, 2014Period from
January 1 to '/>"/>

SOURCE Galmed Pharmaceuticals Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
3. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
4. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
5. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
6. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
7. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
8. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
9. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
10. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
11. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 This is a ... of the Phenolic Resin industry in Global and ... industry, including definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
(Date:9/23/2014)... ATCC, the premier global biological materials resource ... appointments to the senior leadership team. Barbie Bigelow has ... Technology and Dr. Maryellen de Mars also joins as ... roles are new positions at ATCC. ... ATCC described the additions as part of a revitalization ...
(Date:9/23/2014)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced three ... to $5 million. The orders are all odour control projects ... continue to see new orders coming in," said Peter ... has climbed to over $11 million." About ... company that designs, manufactures and distributes a comprehensive line of ...
(Date:9/23/2014)... This is a professional and in-depth ... (IPA) industry. The report provides a basic overview ... chain structure. Global market analysis and Chinese domestic ... history, developments, trends and competitive landscape of the ... situation is also offered. , The report ...
Breaking Biology Technology:Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3
... ... its first relaunch, and came out as a beta. In this relaunch they have focused on ... get more relevant results. They have tried to get the users to get and give a ... , ...
... POMPEY, France, September 17 Novasep is ... - France, specialized in the development,and manufacturing of ... "Potent Compound Safety Certification" from SafeBridge(R),Consultants, Inc. , ... Safety Certification program verifies,Novasep,s performance in the management, ...
... SCOTTSDALE, Ariz., Sept. 17 MedTrust Online, a ... options for challenging patient cancer cases, has surpassed 5,000 ... Online also announced today that world-renowned oncologist Dr. Henry ... advisors. , , "5,000 users is ...
Cached Biology Technology:ePDF is Happy to Announce that ePDF has Completed its First Relaunch, and has Come Out as a Beta 2Novasep Gains SafeBridge(R) "Potent Compound Safety Certification" for its Le Mans Facility 2Novasep Gains SafeBridge(R) "Potent Compound Safety Certification" for its Le Mans Facility 3MedTrust Online Surpasses 5,000 Registered Users and Adds Dr. Henry Friedman to Oncology Advisory Board 2
(Date:9/23/2014)... moving body relies on an orchestrated response of bones, joints, ... literally the geometry of a critical part like ... just a footfall error at the root of one of ... cruciate ligament tear. In fact, size of the femoral ... and volume of the ACL combine to influence the ...
(Date:9/23/2014)... MADISON, Wis. A multidisciplinary team at the University ... creating a faster, more affordable way to screen for ... development. , The National Institutes of Health (NIH) announced ... 11 universities receiving support to continue the promising work ... program. The team will receive approximately $7 million over ...
(Date:9/23/2014)... Health will award funds to support the next phase ... improve ways of predicting drug safety and effectiveness. Researchers ... human tissue chips and combine them into an integrated ... human body. Led by the National Center for Advancing ... at $17 million in 2014 with additional support over ...
Breaking Biology News(10 mins):Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 3UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4
... Leading scientists, physicians, and veterinarians are uncovering new links ... implications for human health. , "Marine mammals are providing ... says Paul Sandifer, Chief Scientist for the new Oceans ... and Atmospheric Administration (NOAA). "There is mounting evidence ...
... there's a constant shuffling of genetic material going ... via ocean-dwelling viruses, scientists report this week in ... Sallie Chisholm and her colleagues at the Massachusetts ... new facet of evolution and helping scientists see ...
... gene responsible for making embryos male and forming the ... by Parkinson's disease. Published in the Feb. 21 ... why more men than women develop the degenerative disorder, ... 1.5 times more likely to develop Parkinson's disease than ...
Cached Biology News:Marine mammals are on the frontline of failing ocean health 2Marine mammals are on the frontline of failing ocean health 3Marine mammals are on the frontline of failing ocean health 4Marine mammals are on the frontline of failing ocean health 5Marine mammals are on the frontline of failing ocean health 6Scientists discover interplay between genes and viruses in tiny ocean plankton 2UCLA scientists find male gene in brain area targeted by Parkinson's 2
... bottoms,• Nonreversible lids with ... contamination,• Individual alphanumerical codes ... footprint for ease in ... cell attachment,• Sterilized by ...
... is a G1 cyclin required for G1-phase ... a proto-oncogene. cyclin D2 can phosphorylate ... Species Reactivity: Human, Mouse, and Rat. ... is particularly well suited for neutralization of ...
... combines shaking and rocking for maximal fluid movement. ... mm stainless steel or acrylic platform, it is ... operation. The platform angle is easily adjusted from ... action and rotation speed of platform is adjusted ...
... PROTEAN II xi 2-D system runs both gel dimensions ... tube gels can be separated in a single run ... cooling core in much the same manner as the ... the second-dimension slab gels may be cast in the ...
Biology Products: